The impact of sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists on insulin utilisation and costs in Australia: a national retrospective observational cross-sectional study
The Lancet Regional Health - Western Pacific, Год журнала: 2024, Номер 52, С. 101207 - 101207
Опубликована: Сен. 24, 2024
Язык: Английский